Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)
39.58
+0.15
(+0.38%)
Streaming Delayed Price
Updated: 10:08 AM EDT, Aug 19, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 80,412 |
| Open | 39.90 |
| Bid (Size) | 39.54 (200) |
| Ask (Size) | 39.62 (200) |
| Prev. Close | 39.43 |
| Today's Range | 39.34 - 40.00 |
| 52wk Range | 22.22 - 42.81 |
| Shares Outstanding | 128,000,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Indivior Q2 Earnings Call Highlights ↗
August 03, 2026
Indivior (INDV) Q1 2026 Earnings Transcript ↗
May 01, 2026
Frequently Asked Questions
Is Indivior Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Indivior Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Indivior Pharmaceuticals, Inc. - Common Stock trade on?
Indivior Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock is INDV on the Nasdaq Stock Market
What is the current price of Indivior Pharmaceuticals, Inc. - Common Stock?
The current price of Indivior Pharmaceuticals, Inc. - Common Stock is 39.58
When was Indivior Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Indivior Pharmaceuticals, Inc. - Common Stock was at 08/19/26 10:08 AM ET
What is the market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock is 5.07B
How many shares of Indivior Pharmaceuticals, Inc. - Common Stock are outstanding?
Indivior Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.